Ipopema Securities SA (IPE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ipopema Securities SA (IPE) has a cash flow conversion efficiency ratio of 0.553x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł82.19 Million ≈ $22.62 Million USD) by net assets (zł148.49 Million ≈ $40.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Ipopema Securities SA for the company's overall valuation and market capitalisation.
Ipopema Securities SA - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how Ipopema Securities SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Ipopema Securities SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ipopema Securities SA ranked by their cash flow conversion efficiency. Explore IPE cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ:TELO
|
-0.357x |
|
Trias Sentosa Tbk
JK:TRST
|
0.029x |
|
INSUN Environmental New Technology Co. Ltd
KQ:060150
|
0.010x |
|
Country Group Holdings Public Company Limited
BK:CGH
|
0.024x |
|
Helix BioPharma Corp.
TO:HBP
|
-0.030x |
|
Sejal Glass Limited
NSE:SEJALLTD
|
0.278x |
|
Woorim Machinery Co. Ltd
KQ:101170
|
-0.035x |
|
Ribbon Acquisition Corp Unit
NASDAQ:RIBBU
|
-0.001x |
Annual Cash Flow Conversion Efficiency for Ipopema Securities SA (2009–2025)
The table below shows the annual cash flow conversion efficiency of Ipopema Securities SA from 2009 to 2025. View IPE share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | zł142.95 Million ≈ $39.34 Million |
zł25.08 Million ≈ $6.90 Million |
0.175x | -59.89% |
| 2024-12-31 | zł127.43 Million ≈ $35.07 Million |
zł55.75 Million ≈ $15.34 Million |
0.438x | +136.39% |
| 2023-12-31 | zł126.85 Million ≈ $34.91 Million |
zł23.48 Million ≈ $6.46 Million |
0.185x | -54.03% |
| 2022-12-31 | zł112.69 Million ≈ $31.01 Million |
zł45.37 Million ≈ $12.49 Million |
0.403x | +131.99% |
| 2021-12-31 | zł116.16 Million ≈ $31.97 Million |
zł-146.21 Million ≈ $-40.24 Million |
-1.259x | -157.94% |
| 2020-12-31 | zł113.96 Million ≈ $31.36 Million |
zł247.59 Million ≈ $68.14 Million |
2.173x | +515.56% |
| 2019-12-31 | zł83.74 Million ≈ $23.05 Million |
zł29.56 Million ≈ $8.13 Million |
0.353x | +442.45% |
| 2018-12-31 | zł80.41 Million ≈ $22.13 Million |
zł-8.29 Million ≈ $-2.28 Million |
-0.103x | -194.92% |
| 2017-12-31 | zł84.20 Million ≈ $23.17 Million |
zł9.14 Million ≈ $2.52 Million |
0.109x | +109.51% |
| 2016-12-31 | zł83.64 Million ≈ $23.02 Million |
zł-95.49 Million ≈ $-26.28 Million |
-1.142x | -193.62% |
| 2015-12-31 | zł84.41 Million ≈ $23.23 Million |
zł102.94 Million ≈ $28.33 Million |
1.220x | +18959.93% |
| 2014-12-31 | zł80.72 Million ≈ $22.22 Million |
zł-522.00K ≈ $-143.66K |
-0.006x | +99.68% |
| 2013-12-31 | zł85.34 Million ≈ $23.49 Million |
zł-173.62 Million ≈ $-47.78 Million |
-2.034x | -191.43% |
| 2012-12-31 | zł75.23 Million ≈ $20.70 Million |
zł167.38 Million ≈ $46.07 Million |
2.225x | +1888.22% |
| 2011-12-31 | zł80.97 Million ≈ $22.28 Million |
zł9.06 Million ≈ $2.49 Million |
0.112x | -87.98% |
| 2010-12-31 | zł69.25 Million ≈ $19.06 Million |
zł64.48 Million ≈ $17.75 Million |
0.931x | +249.86% |
| 2009-12-31 | zł48.54 Million ≈ $13.36 Million |
zł12.92 Million ≈ $3.56 Million |
0.266x | -- |
About Ipopema Securities SA
IPOPEMA Securities S.A., together with its subsidiaries, provides brokerage, company analysis, and investment banking services in Poland. The company engages in the brokerage and investment banking activities; distribution of investment products; and provision of investment advisory services to a range of individual investors, as well as advisory services related to corporate financial restructur… Read more